SLUNF (SLUNF) Stock Price & Analysis
SLUNF (SLUNF) rose 0.00% to USD 2.84 as of June 10, 2026 at 03:41 UTC, according to Nexqual real-time market data.
SLUNF last closed at USD 2.84; the session ranged USD 3.36–3.36 on volume of 9,451 shares. Market capitalization is $304.08M, with a 52-week range of USD 2.84–3.36 (PNK). Source: Nexqual, June 10, 2026 at 03:41 UTC.
Key Statistics (as of June 10, 2026 at 03:41 UTC)
| Price | USD 2.84 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.84 |
| Open | USD 3.36 |
| Day Range | USD 3.36 – 3.36 |
| 52-Week Range | USD 2.84 – 3.36 |
| Volume | 9,451 shares |
| Market Cap | $304.08M |
| Exchange | PNK |
Technical Analysis (SLUNF)
Nexqual's technical model rates SLUNF "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:41 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 2.84) |
| MACD | 0 (negative) |
Analyst Ratings (SLUNF)
Wall Street analysts rate SLUNF "None", per Nexqual as of June 10, 2026 at 03:41 UTC.
| Consensus Rating | None |
|---|
Earnings (SLUNF)
| Next Earnings Date | 2026-03-30 |
|---|
Source: Nexqual, June 10, 2026 at 03:41 UTC.
Financials & Fundamentals (SLUNF)
| Total Revenue | $892.40M |
|---|---|
| Gross Margin | +66.41% |
| Operating Margin | -0.48% |
| Profit Margin | -6.80% |
| ROE | -53.03% |
| Debt / Equity | 368.44 |
| Current Ratio | 0.92 |
| Total Cash | $73.20M |
| Total Debt | $172.80M |
| Free Cash Flow | $27.49M |
Source: Nexqual, June 10, 2026 at 03:41 UTC.
Financial Health Score (SLUNF)
Nexqual rates SLUNF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:41 UTC.
| Growth | Critical — Revenue -10% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 66%, operating -0% |
| Balance Sheet | Critical — $73M cash vs $173M debt |
| Cash Flow | Mixed — FCF $27M, slim 3.1% margin |
| Efficiency | Critical — ROE -53%, ROA -0.4% |
Ownership (SLUNF)
| Insider Ownership | +16.20% |
|---|---|
| Institutional Ownership | +2.55% |
| Shares Outstanding | 107.07M |
| Float | 89.77M |
Source: Nexqual, June 10, 2026 at 03:41 UTC.
Leadership (SLUNF)
SLUNF is led by Gianbeppi Fortis (age 60), Co-Founder, Chairman of Executive Board & CEO, per Nexqual as of June 10, 2026 at 03:41 UTC.
| Co-Founder, Chairman of Executive Board & CEO | Gianbeppi Fortis (age 60) |
|---|---|
| MD, Co-CEO of Operations in Germany, Chief Revenue Officer & Member of Management Board | Luc Brusselaers (age 63) |
| COO & Member of Management Board | Wojciech Pomykala (age 49) |
| Group HR Director | Denis Coleu |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WTRNF | WESTERN RESOURCES CORP | USD 0 | ▲ 0% |
| GSGTF | GENSIGHT BIOLOGICS SA | USD 0.19 | ▲ 0% |
| ECXJ | CXJ Group Co Limited | USD 1.8 | ▲ 36.36% |
| GLHD | PSH GROUP HLDG INC | USD 0 | ▲ 0% |
| YTESTQFTACHYON | TACHYON HEARBEAT | USD 232.82 | ▼ 75.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:41 UTC. This page is informational and not investment advice.